Time-Restricted Eating Improves Glycemic Regulation in Metabolic Syndrome
By Elana Gotkine HealthDay Reporter
.jpg?width=1200)
MONDAY, Sept. 30, 2024 -- Time-restricted eating (TRE), limiting dietary intake to eight to 10 hours without mandating calorie restriction, combined with standard-of-care (SOC) nutritional counseling improves glycemic regulation among adults with metabolic syndrome (MetS), according to a study published online Oct. 1 in the Annals of Internal Medicine.
Emily N.C. Manoogian, Ph.D., from the Salk Institute for Biological Studies in La Jolla, California, and colleagues examined the effect of TRE as a lifestyle intervention combined with current SOC treatments on cardiometabolic health in adults with MetS with elevated fasting glucose or hemoglobin A1c (HbA1c). Participants were randomly assigned to SOC nutritional counseling alone (SOC group) or combined with a personalized eight- to 10-hour TRE intervention (greater than or equal to a four-hour reduction in eating window) for three months. The myCircadianClock smartphone application was used to track the timing of dietary intake in real time.
The intervention was completed by 108 participants (89 percent of those randomly assigned). The researchers found that TRE improved HbA1c by −0.10 percent compared with SOC. With age, there was adjustment in statistical outcomes. No major adverse events occurred.
"TRE is an effective lifestyle strategy that can be used concomitantly with the current SOC pharmacotherapies and nutritional counseling to further improve glycemic regulation and potentially multiple components of cardiometabolic health in patients with MetS," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Degree of Weight Loss Affects Tirzepatide-Linked Cardiometabolic Risk Improvement
TUESDAY, July 1, 2025 -- For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction...
American Diabetes Association, June 20-23
The annual meeting of the American Diabetes Association was held this year from June 20 to 23 in Chicago, drawing more than 15,000 participants, including clinicians...
Muscle Ultrasound Can Detect Insulin Resistance
MONDAY, June 30, 2025 -- Muscle ultrasound can detect insulin resistance and lower muscle mass, according to a study published online June 12 in the Journal of Ultrasound...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.